Autoimmune hepatitis in practice, from diagnosis to complications : What is the role of imaging? A clinicoradiological review
Copyright © 2021 Elsevier Inc. All rights reserved..
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unknown origin that can lead to liver cirrhosis, hepatocellular carcinoma (HCC), liver transplantation or death. The diagnosis is performed upon a multifactorial score. Treatment is based on the combination of immunosuppressants and aims at clinical, laboratory and histological remission, the latter being the most difficult to be achieved and proven. The absence of liver inflammation, defined by biopsy, is the main determinant in remission or therapeutic modification. Imaging exams have a limited role in this clinical management and the main findings are those related to chronic liver disease. Imaging's relevance, therefore, lies mainly in helping to exclude overlapping syndromes and in assessing complications related to cirrhosis, such as in screening for HCC. In recent years, however, the radiological literature has been witnessing increasing advances with regard to imaging biomarkers in liver disease, leading some authors to consider a future of virtual liver biopsy performed by magnetic resonance imaging. The present study aims to review the role of imaging in the management of AIH in the light of recent advances in the current literature and to provide an illustrated guide with the main findings described in the disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
---|---|
Enthalten in: |
Clinical imaging - 74(2021) vom: 05. Juni, Seite 31-40 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gomes, Natália Borges Nunes [VerfasserIn] |
---|
Links: |
---|
Themen: |
Diagnostic imaging |
---|
Anmerkungen: |
Date Completed 27.04.2021 Date Revised 27.04.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.clinimag.2020.12.032 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319926044 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319926044 | ||
003 | DE-627 | ||
005 | 20231225172506.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clinimag.2020.12.032 |2 doi | |
028 | 5 | 2 | |a pubmed24n1066.xml |
035 | |a (DE-627)NLM319926044 | ||
035 | |a (NLM)33429144 | ||
035 | |a (PII)S0899-7071(20)30548-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gomes, Natália Borges Nunes |e verfasserin |4 aut | |
245 | 1 | 0 | |a Autoimmune hepatitis in practice, from diagnosis to complications |b What is the role of imaging? A clinicoradiological review |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.04.2021 | ||
500 | |a Date Revised 27.04.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unknown origin that can lead to liver cirrhosis, hepatocellular carcinoma (HCC), liver transplantation or death. The diagnosis is performed upon a multifactorial score. Treatment is based on the combination of immunosuppressants and aims at clinical, laboratory and histological remission, the latter being the most difficult to be achieved and proven. The absence of liver inflammation, defined by biopsy, is the main determinant in remission or therapeutic modification. Imaging exams have a limited role in this clinical management and the main findings are those related to chronic liver disease. Imaging's relevance, therefore, lies mainly in helping to exclude overlapping syndromes and in assessing complications related to cirrhosis, such as in screening for HCC. In recent years, however, the radiological literature has been witnessing increasing advances with regard to imaging biomarkers in liver disease, leading some authors to consider a future of virtual liver biopsy performed by magnetic resonance imaging. The present study aims to review the role of imaging in the management of AIH in the light of recent advances in the current literature and to provide an illustrated guide with the main findings described in the disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Diagnostic imaging | |
650 | 4 | |a Hepatitis, autoimmune | |
650 | 4 | |a Hepatitis, chronic | |
700 | 1 | |a Torres, Ulysses S |e verfasserin |4 aut | |
700 | 1 | |a Ferraz, Maria Lucia Cardoso Gomes |e verfasserin |4 aut | |
700 | 1 | |a D'Ippolito, Giuseppe |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical imaging |d 1996 |g 74(2021) vom: 05. Juni, Seite 31-40 |w (DE-627)NLM012624381 |x 1873-4499 |7 nnns |
773 | 1 | 8 | |g volume:74 |g year:2021 |g day:05 |g month:06 |g pages:31-40 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clinimag.2020.12.032 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 74 |j 2021 |b 05 |c 06 |h 31-40 |